Obesity is associated with chronic low-grade inflammation in key metabolic tissues, including adipose tissue, the liver, skeletal muscle, pancreatic islets, and the brain. This persistent inflammation plays a significant role in metabolic dysfunction and related health complications.

Did you know?
The American Heart Association advises at least 150 minutes of moderate-intensity exercise per week to support overall health and well-being.

Pharmacological interventions : Emerging therapies

Traditional anti-obesity medications typically result in a 3% to 7% reduction in body weight. However, newer therapies, such as Semaglutide (Ozempic) and Tirzepatide (not yet available in South Africa), have shown greater effectiveness in promoting weight loss.

GLP-1 receptor agonists, like Ozempic, not only help regulate blood glucose levels and support weight loss but also reduce the risk of major cardiovascular events, including cardiovascular-related mortality, non-fatal stroke, and myocardial infarction in individuals with diabetes.

For a weight loss assessment and pharmacological measures options book an appointment with Dr Wendy today!